Who is William C. Weldon and why was he appointed to the Board?

William C. Weldon is the former Chairman and CEO of Johnson & Johnson. He was appointed to the CVS Caremark Board of Directors to leverage his extensive experience in managing a large, global healthcare company and his deep understanding of the highly regulated healthcare market.

What does it mean for CVS Caremark to have an independent director?

An independent director is a director who does not have a material relationship with the company, other than their service on the board. This independence is crucial for good corporate governance as it ensures the director can exercise objective judgment and act in the best interests of all shareholders, free from potential conflicts of interest.

What were the nature of the business dealings between CVS Caremark and Johnson & Johnson?

CVS Caremark purchased approximately $740 million worth of products from Johnson & Johnson in 2012, both directly and through third parties. Additionally, Johnson & Johnson provided CVS Caremark with rebates for prescription drug dispenses, which are customary in the industry. The majority of these rebates were passed on to CVS Caremark's clients.

CVS 8-K: Leadership Changes

Q: Are there any conflicts of interest due to Mr. Weldon's previous role at Johnson & Johnson?

CVS Caremark had significant business dealings with Johnson & Johnson, including approximately $740 million in product purchases in 2012. However, the company stated these transactions were conducted in the ordinary course of business on an arm's-length basis, and Mr. Weldon was not involved in negotiating these specific arrangements. The Board determined him to be an independent director.

Summary

This 8-K filing from CVS Caremark Corporation (now CVS Health) on March 29, 2013, primarily announced the appointment of William C. Weldon to its Board of Directors. Mr. Weldon brings extensive experience as the former Chairman and CEO of Johnson & Johnson, a major healthcare product manufacturer. His appointment is expected to enhance the board's expertise in managing a complex global healthcare company and navigating the highly regulated industry. While Mr. Weldon's background with Johnson & Johnson presents a potential conflict of interest due to significant business dealings between CVS Caremark and J&J, the filing clarifies that these transactions were conducted in the ordinary course of business on an arm's-length basis. Mr. Weldon was not involved in these specific negotiations. The board determined him to be an independent director according to NYSE and company guidelines, considering his lack of direct involvement in the business dealings between the two corporations.

Key Highlights

1Appointment of William C. Weldon to the Board of Directors.
2Mr. Weldon's extensive background as former Chairman and CEO of Johnson & Johnson.
3Board's rationale for Mr. Weldon's appointment: expertise in global healthcare management and regulated industries.
4Disclosure of material business relationships between CVS Caremark and Johnson & Johnson ($740 million in product purchases in 2012).
5Confirmation that business dealings were in the ordinary course and on an arm's-length basis.
6Statement that Mr. Weldon was not involved in specific negotiations between CVS Caremark and Johnson & Johnson.
7Determination of Mr. Weldon's independence by the Board, adhering to NYSE and company governance standards.

CVS HEALTH Corp 8-K Report, Executive Changes (Mar 29, 2013)

Summary

Key Highlights

Frequently Asked Questions